In this episode of Drug Digest, industry experts discuss the ongoing development of automating biomanufacturing processes, including its challenges and practical applications.
The biopharmaceutical industry has seen the use of automated technologies in biomanufacturing processes grow over the years from theory to reality. In this episode of Drug Digest, industry experts discuss the ongoing advancement of automation in the biopharmaceutical industry. They give insight into how automated technologies are put to use today and how they are streamlining process development, with an eye toward saving cost, time, and manufacturing footprint.
John Hatzis, Global Life Sciences Industry Consultant, Rockwell Automation
John Hatzis has been with Rockwell Automation for ten years where he has leveraged his expertise using Rockwell technology in a variety of applications in the Life Sciences industry. He works with BiofabUSA consulting on control systems for new tissue therapies. John has a BSc in Chemical Engineering from Worcester Polytechnic Institute.
Smriti Khera, Global Head of Life Sciences Strategy and Marketing, Rockwell Automation
Smriti Khera is the global head of Life Sciences Strategy and Marketing at Rockwell Automation. She holds a PhD in Pharmaceutical Sciences from the University of Arizona, where her focus was drug discovery from natural products. After working as a pharma research scientist, she pivoted to strategic marketing to increase her impact. Over the past 12 years she has held strategy and marketing leadership roles with increasing levels of responsibilities at both Fortune 500 and early stage startups. She is passionate about leveraging her unique expertise to generate sustained impact across healthcare and life sciences using automation and digital technologies.
This episode of Drug Digest is sponsored by:
Drug Digest is a tech talk video series with the Pharmaceutical Technology® editors, who interview industry experts to discuss the emerging opportunities, obstacles, and advances in the pharmaceutical and biopharmaceutical industry for the research, development, formulation, analysis, upstream and downstream processing, manufacturing, supply chain, and packaging of drug products.